Title: Graham C Parry: Innovator in Cancer Diagnostics and Therapy
Introduction
Graham C Parry is a notable inventor based in the United States. He has made significant contributions to the field of cancer diagnostics and therapy through his innovative research. His work focuses on the interactions of specific proteins that play a crucial role in cancer progression.
Latest Patents
Graham C Parry holds a patent titled "Ligands Binding The Complex Of Urokinase-Type Plasminogen Activator (uPA) And Its Receptor (uPAR) That Inhibit Downstream uPAR Interactions: Identification And Use In Diagnosis Or Therapy." This patent involves antibodies or other ligands that specifically target the binary uPA-uPAR complexes. These ligands inhibit the interaction of uPA and uPAR with additional molecules, which is particularly relevant in cancer treatment.
Career Highlights
Graham C Parry has been associated with Attenuon, LLC, where he continues to advance his research in the field. His work has been instrumental in developing diagnostic and therapeutic methods that leverage the unique properties of the uPA-uPAR complex.
Collaborations
Graham collaborates with Andrew P Mazar, who is also involved in similar research areas. Their partnership enhances the potential for breakthroughs in cancer diagnostics and treatment.
Conclusion
Graham C Parry's innovative work in the field of cancer research highlights the importance of understanding protein interactions in developing effective therapies. His contributions are paving the way for advancements in cancer diagnostics and treatment methodologies.